News & Press Releases
Filter by:
Mintz Advises on Protara Therapeutics' $75 Million Public Offering
December 16, 2025
Mintz Advises on Fulcrum Therapeutics' $175 Million Public Offering
December 16, 2025
Mintz advised the underwriters in connection with Fulcrum Therapeutics' $175 million public offering.
Mintz Advises on Wave Life Sciences $402.5 Million Public Offering
December 12, 2025
Mintz advised Wave Life Sciences in its $402.5 million public offering.
Mintz advised Cultivo, a leading platform for developing and operating natural assets at scale, on its acquisition of leading carbon grasslands project developer Kateri.
Mintz Advises on Capricor Therapeutics’ $150 Million Public Offering
December 10, 2025
Mintz advised the underwriters in connection with Capricor Therapeutics’ $150 million public offering.
Mintz Advises SILAC on Acquisition by Hildene Capital Management
December 10, 2025
Mintz advised SILAC, Inc., the parent company of SILAC Insurance Company (“SILAC”), a leading provider of fixed and fixed indexed annuity products in the US, on its definitive agreement to be acquired by Hildene Capital Management, an $18+ billion credit-focused alternative asset manager, for approximately $550 million in cash.
